MEMBER SIGN IN

BP Success Zone



Brought to you by:

Diovan Logo

Diovan HCT Logo

Exforge Logo

Tekturna Logo


 Member Login

 e-mail

password

¡Muy pronto en español
If you don't have prescription coverage and can't afford your medicines, visit: www.pap.novartis.com or call 1-800-245-5356

Enrolling New Patients



Change Text Size Decrease Font Increase Font Increase Font

Enrolling Your Patients

The BP Success Zone Program is an educational program that provides valuable information, support and helpful tools to help your patients manage their blood pressure.

Enrolling your patients is simple:

Once a patient has visited their healthcare professional and been prescribed DIOVAN, DIOVAN HCT, EXFORGE or TEKTURNA, their healthcare professional will give them a BP Success Zone Program kit. This kit contains a free sample prescription for DIOVAN, DIOVAN HCT, EXFORGE or TEKTURNA and a membership card good for up to $10 off their first Novartis blood pressure medication and other offers. This offer is open to all those taking a select Novartis blood pressure medication.

* Restrictions apply. Please see Terms and Conditions for a list of exclusions.

To enroll in the BP Success Zone Program, patients can call 1-866-630-0350 or go online to www.BPSuccessZone.com to enroll.
Once enrolled, members can take their membership card to any participating pharmacy to take advantage of up to $10 off their first prescription of a select Novartis blood pressure medication.

The BP Success Zone Program gives your patients exclusive benefits such as:

A free sample prescription for DIOVAN, DIOVAN HCT, EXFORGE or TEKTURNA.*
An Omron blood pressure monitor, free with rebate (up to $40 value).**
Ongoing educational support materials, including the latest high blood pressure information from sources you can trust.
A Healthy Lifestyle Action Plan for reducing salt (sodium) in your diet, losing weight, increasing physical activity, managing stress or stopping smoking.
Members' Web site tools like the BP Tracker to help your patients track their progress as they lower their blood pressure.
The BP Goal Money-Back Guarantee.***

**Omron® is a registered trademark of Omron Healthcare, Inc. Limitations apply. See Terms and Conditions.

** Limitations apply. See Terms and Conditions for Program details. Novartis reserves the right to change Program benefits at any time.

AS A PHARMACIST, YOU HAVE THE OPPORTUNITY TO HELP YOUR HYPERTENSIVE PATIENTS GET INTO THE BP SUCCESS ZONE.

By encouraging your patients to talk to their healthcare professionals about enrolling in the BP Success Zone Program, you are helping them get on the road to successfully managing their blood pressure.

ANY QUESTIONS?

Can a LOTREL® (amlodipine besylate/benazepril HCl) capsule user who enrolled in the Program before October 31, 2007 still get the benefits of the BP Success Zone Program (Omron rebate or money-back guarantee)?

Patients who enrolled in the BP Success Zone Program before October 31, 2007 still qualify for the Omron® rebate and money-back guarantee. Request the necessary forms by calling 1-866-968-7270. After filling out the forms, patients should send them in with the required information to receive a refund or reimbursement.

Patients who did not enroll prior to October 31, 2007 do not qualify for the benefits of the BP Success Zone Program.

How can patients get reimbursed for their LOTREL prescription?

Unfortunately, LOTREL is no longer part of the BP Success Zone Program. Patients who enrolled before October 31, 2007 and have not used their membership card can request a co-pay assistance form for their next LOTREL prescription fill or refill.

Visit our Frequently Asked Questions Section if you have any other questions. We're also standing by to help at 1-866-968-7270. Live operator support is available from 8:00 a.m. to 5:30 p.m. EST, Monday through Friday. During the hours of 5:30 p.m. to 9:00 p.m. EST, Monday through Friday and on Saturdays from 9:00 a.m. to 3:00 p.m. EST we offer after-hour support with on-call agents who will return your call within approximately 15 minutes.

LOTREL is indicated for the treatment of hypertension; it is not indicated for the initial treatment of hypertension.

African American patients receiving ACEIs have been reported to have a higher incidence of angioedema compared with non-African Americans.

Important Considerations

USE IN PREGNANCY: When used in pregnancy ACEIs can cause injury and even death to the developing fetus. When pregnancy is detected, LOTREL should be discontinued as soon as possible. See WARNINGS, Fetal/Neonatal Morbidity and Mortality.

LOTREL is contraindicated in patients who are hypersensitive to benazepril, to any other ACEI, or to amlodipine.

Angioedema has been reported in patients receiving LOTREL. In placebo-controlled clinical trials, the most common adverse events vs placebo were cough (3.3% vs 0.2%), headache (2.2% vs 5.6%), edema (2.1% vs 2.2%), and dizziness (1.3% vs 1.5%).


Doctors
Terms and Conditions See Terms and Conditions Click here Click here








BP Success Zone Program Homepage  |  Professional Main Page
About the Program  |  Request Kits  |  Pharmacist Resources  |  FAQs

Contact Us  |  Site Guide  |  Site Map



  


Use of website is governed by the Terms of Use and Privacy Statement
Copyright ©2007 Novartis Pharmaceuticals Corporation. All rights reserved.


Novartis proudly supports the Together Rx Access program.
Together Rx Access